Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 5
1974 6
1975 14
1976 16
1977 29
1978 19
1979 25
1980 32
1981 32
1982 20
1983 31
1984 16
1985 27
1986 27
1987 50
1988 45
1989 38
1990 39
1991 28
1992 28
1993 24
1994 36
1995 22
1996 14
1997 13
1998 21
1999 12
2000 20
2001 18
2002 20
2003 16
2004 15
2005 13
2006 5
2007 22
2008 14
2009 16
2010 23
2011 23
2012 18
2013 21
2014 20
2015 27
2016 35
2017 27
2018 34
2019 34
2020 51
2021 25
2022 35
2023 45
2024 86
2025 86
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,332 results

Results by year

Filters applied: . Clear all
Page 1
Minoxidil and its use in hair disorders: a review.
Suchonwanit P, Thammarucha S, Leerunyakul K. Suchonwanit P, et al. Drug Des Devel Ther. 2019 Aug 9;13:2777-2786. doi: 10.2147/DDDT.S214907. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31496654 Free PMC article. Review.
Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia.
Jimenez-Cauhe J, Saceda-Corralo D, Rodrigues-Barata R, Hermosa-Gelbard A, Moreno-Arrones OM, Fernandez-Nieto D, Vaño-Galvan S. Jimenez-Cauhe J, et al. J Am Acad Dermatol. 2019 Aug;81(2):648-649. doi: 10.1016/j.jaad.2019.04.054. Epub 2019 May 2. J Am Acad Dermatol. 2019. PMID: 31054970 No abstract available.
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, Moreno-Arrones ÓM, Saceda-Corralo D, Rodrigues-Barata R, Jimenez-Cauhe J, Koh WL, Poa JE, Jerjen R, Trindade de Carvalho L, John JM, Salas-Callo CI, Vincenzi C, Yin L, Lo-Sicco K, Waskiel-Burnat A, Starace M, Zamorano JL, Jaén-Olasolo P, Piraccini BM, Rudnicka L, Shapiro J, Tosti A, Sinclair R, Bhoyrul B. Vañó-Galván S, et al. J Am Acad Dermatol. 2021 Jun;84(6):1644-1651. doi: 10.1016/j.jaad.2021.02.054. Epub 2021 Feb 24. J Am Acad Dermatol. 2021. PMID: 33639244
Minoxidil use in dermatology, side effects and recent patents.
Rossi A, Cantisani C, Melis L, Iorio A, Scali E, Calvieri S. Rossi A, et al. Recent Pat Inflamm Allergy Drug Discov. 2012 May;6(2):130-6. doi: 10.2174/187221312800166859. Recent Pat Inflamm Allergy Drug Discov. 2012. PMID: 22409453 Review.
Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus Statement.
Akiska YM, Mirmirani P, Roseborough I, Mathes E, Bhutani T, Ambrosy A, Aguh C, Bergfeld W, Callender VD, Castelo-Soccio L, Cotsarelis G, Craiglow BG, Desai NS, Doche I, Duque-Estrada B, Elston DM, Goh C, Goldberg LJ, Grimalt R, Jabbari A, Jolliffe V, King BA, LaSenna C, Lenzy Y, Lester JC, Lortkipanidze N, Lo Sicco KI, McMichael A, Meah N, Mesinkovska N, Miteva M, Mostaghimi A, Ovcharenko Y, Piliang M, Piraccini BM, Rakowska A, Salkey KS, Schmidt A, Shapiro J, Sibbald C, Sinclair R, Suchonwanit P, Taylor S, Tosti A, Vañó-Galván S, Wall DR, Fu JM. Akiska YM, et al. JAMA Dermatol. 2025 Jan 1;161(1):87-95. doi: 10.1001/jamadermatol.2024.4593. JAMA Dermatol. 2025. PMID: 39565602 Free article.
Androgenetic alopecia.
Piraccini BM, Alessandrini A. Piraccini BM, et al. G Ital Dermatol Venereol. 2014 Feb;149(1):15-24. G Ital Dermatol Venereol. 2014. PMID: 24566563 Review.
1,332 results